Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Vycor Medical (VYCO) Return on Capital Employed (2016 - 2025)

Vycor Medical has reported Return on Capital Employed over the past 15 years, most recently at 0.87% for Q4 2025.

  • Quarterly Return on Capital Employed fell 152.0% to 0.87% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.87% through Dec 2025, down 152.0% year-over-year, with the annual reading at 0.88% for FY2025, 152.0% down from the prior year.
  • Return on Capital Employed was 0.87% for Q4 2025 at Vycor Medical, up from 1.96% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 38.63% in Q1 2021 and troughed at 1.96% in Q3 2025.
  • The 5-year median for Return on Capital Employed is 2.56% (2024), against an average of 8.59%.
  • Year-over-year, Return on Capital Employed tumbled -2696bps in 2022 and then surged 306bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 20.16% in 2021, then crashed by -45bps to 11.15% in 2022, then plummeted by -112bps to 1.32% in 2023, then surged by 149bps to 0.65% in 2024, then tumbled by -234bps to 0.87% in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Return on Capital Employed are 0.87% (Q4 2025), 1.96% (Q3 2025), and 0.25% (Q2 2025).